Evidence map›Paper›PMID 36776337›Full record

ArticleFrontiers in oncology2023

Extraskeletal Ewing's sarcoma of the mediastinum: Case report.

Aldo Caltavituro, Roberto Buonaiuto, Fabio Salomone, Rocco Morra, Erica Pietroluongo, Pietro De Placido, Marianna Tortora, Annarita Peddio, Fernanda Picozzi, Margaret Ottaviano and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Ewing sarcoma presenting in the lung: a case report.Journal of medical case reports · 2024
    Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Aldo CaltavituroCRCTR Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy.
Roberto BuonaiutoCRCTR Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy.
Fabio SalomoneCRCTR Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy.
Rocco MorraCRCTR Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy.
Erica PietroluongoCRCTR Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy.
Pietro De PlacidoCRCTR Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy.
Marianna TortoraRare Tumors Coordinating Center of Campania Region (CRCTR) Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy.
Annarita PeddioCRCTR Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy.
Fernanda PicozziDivision of Medical Oncology, Azienda Ospedaliera di Rilievo Nazionale (A.O.R.N.) dei COLLI "Ospedali Monaldi-Cotugno-Centro Traumatologico Ortopedico (CTO)", Naples, Italy.
Margaret OttavianoUnit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Mirella MarinoDepartment of Pathology, Regina Elena National Cancer Institute, Rome, Italy.
Sabino De PlacidoCRCTR Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy.
Giovannella PalmieriRare Tumors Coordinating Center of Campania Region (CRCTR) Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy.
Mario GiulianoCRCTR Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy.
Regione Campania · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ewing sarcoma (ES) represents the second most common malignant bone tumor in children and young adults. ES is not a frequent finding in sites different from the skeletal. Common sites of appearance of ES are lower extremities, the pelvis, paravertebral spaces and head and neck. Primary extraskeletal ES located in the anterior mediastinum are very rare. These neoplasms should be discussed in specialized contests with a high volume of patients treated. Here, we present an uncommon mediastinal mass challenging in its characterization and management. Case description: A thirty-year-old woman performed a thoracic CT scan for dyspnea and persistent cough. Imaging showed a solid mass of 14 x 11 cm involving the left thorax with mediastinal deviation to the right side. Patient underwent an en bloc resection of the mass. Initial histological examination was suggestive for B3 thymoma/thymic carcinoma. Patient was then referred to our rare tumor reference center where a histological review excluded the diagnosis of thymic/thymoma neoplasms meanwhile a third revision assessed a diagnosis of ES. Patient refused adjuvant chemotherapy due to her desire of maternity and radiation therapy was not indicated because surgery was performed too many months earlier. A close follow-up was considered. After a few months the patient relapsed and first line chemotherapy was proposed. She reached a complete response at the first evaluation maintained also at the end of the protocol. In order to consolidate the obtained response, high dose chemotherapy followed by autologous stem cell transplantation (HDCT/ASCT) was suggested and the patient agreed. Conclusions: This case underlined that, potentially, ES can arise from any soft tissue site in the body, even in rare sites such as mediastinum. The evaluation of expert centers was critical to establish a correct diagnosis and therapeutic approach in this complex case. Taking into account the time lasting from the diagnosis and the aggressiveness of this kind of neoplasm, frequently relapsing, the patient after a multidisciplinary discussion was a candidate for a multimodal treatment.

Indexed as

case reportEwing sarcomamisdiagnosis cancermultidisciplinary managementthoracic oncology

Identifiers

PMID36776337
PMCPMC9911166
OpenAlexW4318067678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.